𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pleiotropic actions of suramin on the proliferation of human breast-cancer cells in vitro

✍ Scribed by John A. Foekens; Anieta M. Sieuwerts; Elisabeth M. J. Stuurman-Smeets; Lambert C. J. Dorssers; Els M. J. J. Berns; Jan G. M. Klijn

Publisher
John Wiley and Sons
Year
1992
Tongue
French
Weight
749 KB
Volume
51
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Suramin, a non‐specific growth factor antagonist, is currently under investigation for treatment of cancer patients. We studied its action on 6 different human breast‐cancer cell lines in vitro. In complete growth medium, pleiotropic effects were observed with respect to cell proliferation, i.e. suramin is stimulatory at low concentrations and inhibitory at higher concentrations, for 4 of the 6 cell lines studied. The various cell lines showed marked differences with respect to the antiproliferative action of suramin, the Evsa‐T cells being by far the most sensitive ones. A suramin concentration of 100 μg/ml brought about a 100% stimulation of the proliferation of ZR/HERc cells, ZR 75.1 cells ectopically expressing a human epidermal growth factor receptor (EGF‐R) cDNA. Although less pronounced (10 to 60% stimulation), a similar response was observed for the parent ZR 75.1 cells, as well as for T‐47D and MDA‐MB‐231 cells. The non‐specificity of the action of suramin was established by the observation that suramin‐induced inhibition of cell proliferation could be abolished by insulin‐like growth factor‐1 (IGF‐I) or basic fibroblast growth factor (bFGF), and even by estradiol, both in complete growth medium and under defined serum‐free conditions. Our data indicate that suramin exerts pleiotropic effects on the proliferation of human breast cancer cells in vitro, and confirm the non‐specific nature of its action. The stimulatory effect of low concentrations of suramin on the proliferation of breast cancer cells may have important consequences for breast cancer patients treated with suramin.

📜 SIMILAR VOLUMES

Inhibition of cell proliferation and the
Inhibition of cell proliferation and the action mechanisms of arsenic trioxide (As2O3) on human breast cancer cells
✍ Stephanie K.Y. Chow; Judy Y.W. Chan; K.P. Fung 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 477 KB 👁 1 views

## Abstract Arsenic trioxide (As~2~O~3~) is one of the arsenic compounds found in nature. As~2~O~3~ has recently been used to treat patients suffering from retinoic acid receptor (AML). It is of clinical interest to investigate whether As~2~O~3~ is also effective in treating solid tumors. Here, we

Proliferation of human breast cancer cel
Proliferation of human breast cancer cells and anti-cancer action of doxorubicin and vinblastine are independent of PKC-α
✍ Daniel SD Liu; Chad E. Krebs; Shi J. Liu 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 608 KB

## Abstract Protein kinase C (PKC) has been considered for a potential target of anticancer chemotherapy. PKC‐α has been associated with growth and metastasis of some cancer cells. However, the role of PKC‐α in human breast cancer cell proliferation and anticancer chemotherapy remains unclear. In t

Actions of medroxyprogesterone acetate o
Actions of medroxyprogesterone acetate on the efficacy of cytotoxic drugs: Studies with human breast cancer cells in culture
✍ Naeem A. Shaikh; Alison M. Owen; Margaret W. Ghilchik; Hannelore Braunsberg 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 French ⚖ 632 KB

Human breast cancer cells (MCF-7) showed increased responses to methotrexate and vincristine after a 48-hr pretreatment with medroxyprogesterone acetate. The effect of the hormone, which was detectable at concentrations of between 10 and IOOnM, was independent of its growth-inhibitory action. These

Enterolactone restricts the proliferatio
Enterolactone restricts the proliferation of the LNCaP human prostate cancer cell line in vitro
✍ Mark J. McCann; Chris I. R. Gill; Trevor Linton; D. Berrar; Hugh McGlynn; Ian R. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 550 KB

## Abstract Ecological data suggest a long‐term diet high in plant material rich in biologically active compounds, such as the lignans, can significantly influence the development of prostate cancer over the lifetime of an individual. The capacity of a pure mammalian lignan, enterolactone (ENL), to